Iconic Therapeutics Signs Ophthalmology Option Agreement

by Business Wire • 2019/08/22 • 0 Comments

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--iconic and novartis sign option deal in ophthalmology

← ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-Treatment Regimen Administered Every Two Months

Alcon posts $390 million quarterly net loss →